Search

Your search keyword '"Hofmann‐Lehmann, R."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Hofmann‐Lehmann, R." Remove constraint Author: "Hofmann‐Lehmann, R." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
56 results on '"Hofmann‐Lehmann, R."'

Search Results

1. Antiviral therapy in cats progressively infected with feline leukaemia virus: lessons from a series of 18 consecutive cases from Australia.

2. Vollständige Heilung und Viruselimination bei feliner infektiöser Peritonitis durch orale Gabe von GS-441524 – Follow-up Untersuchung und postmortale Befunde einer genesenen Katze

Catalog

Books, media, physical & digital resources

3. Langzeitbeobachtung von Katzen mit feliner infektiöser Peritonitis nach erfolgreicher Therapie mit oral verabreichtem GS-441524

4. Das Ende einer bisher tödlichen Krankheit? Therapie von Katzen mit infektiöser Peritonitis mit einem oralen antiviralen Medikament

7. Feline Papillomatosis.

8. Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies.

9. Complement Evasion Protects FCoV from Virus Clearance Within Prototypic FIP Lesions.

10. Investigations on the Potential Role of Free-Ranging Wildlife as a Reservoir of SARS-CoV-2 in Switzerland.

11. Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study.

12. Neutrophil Oxidative Burst Profile Is Related to a Satisfactory Response to Itraconazole and Clinical Cure in Feline Sporotrichosis.

13. Canine Cerebrospinal Fluid Analysis Using Two New Automated Techniques: The Sysmex XN-V Body Fluid Mode and an Artificial-Intelligence-Based Algorithm.

14. Alpha-1-Acid Glycoprotein Quantification via Spatial Proximity Analyte Reagent Capture Luminescence Assay: Application as Diagnostic and Prognostic Marker in Serum and Effusions of Cats with Feline Infectious Peritonitis Undergoing GS-441524 Therapy.

15. Evaluation of a Revised Point-of-Care Test for the Detection of Feline Leukaemia p27 Antigen and Anti-p15E Antibodies in Cats.

16. Detection of SARS-CoV-2 RNA in a Zoo-Kept Red Fox ( Vulpes vulpes ).

17. Long-term surveillance of the feline leukemia virus in the endangered Iberian lynx (Lynx pardinus) in Andalusia, Spain (2008-2021).

18. Prospective Investigation of Feline Leukemia Virus Infection in Stray Cats Subjected to a Trap-Neuter-Return Program in Switzerland.

19. Comparison of Sysmex XN-V body fluid mode and deep-learning-based quantification with manual techniques for total nucleated cell count and differential count for equine bronchoalveolar lavage samples.

20. Serological and Molecular Investigation of SARS-CoV-2 in Horses and Cattle in Switzerland from 2020 to 2022.

21. Validation of the Sysmex XN-V Automated Nucleated Red Blood Cell Enumeration for Canine and Feline EDTA-Anticoagulated Blood.

22. Epidemiology of Pathogenic Retroviruses and Domestic Cat Hepadnavirus in Community and Client-Owned Cats in Hong Kong.

23. Acidification is required for calcium and magnesium concentration measurements in equine urine.

24. Findings Related to Cerebrospinal Fluid and Central Nervous System Disorders in Small Ruminants-A Retrospective Study on Sheep and Goats.

25. Feline Morbillivirus: Clinical Relevance of a Widespread Endemic Viral Infection of Cats.

26. Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines.

27. Differences in selected blood parameters between brachycephalic and non-brachycephalic dogs.

28. Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries.

29. Feline Injection-Site Sarcoma and Other Adverse Reactions to Vaccination in Cats.

30. Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524.

31. Patterns of Feline Coronavirus Shedding and Associated Factors in Cats from Breeding Catteries.

33. Methemoglobinemia, Increased Deformability and Reduced Membrane Stability of Red Blood Cells in a Cat with a CYB5R3 Splice Defect.

34. A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households.

35. Clinical features and long-term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone.

36. Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany.

37. Secondary zoonotic dog-to-human transmission of SARS-CoV-2 suggested by timeline but refuted by viral genome sequencing.

38. Detection and Molecular Characterization of the SARS-CoV-2 Delta Variant and the Specific Immune Response in Companion Animals in Switzerland.

40. Clinical Follow-Up and Postmortem Findings in a Cat That Was Cured of Feline Infectious Peritonitis with an Oral Antiviral Drug Containing GS-441524.

41. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection.

42. Detection of Feline Coronavirus Variants in Cats without Feline Infectious Peritonitis.

43. Vaccination and Antibody Testing in Cats.

44. [Feline leukemia virus infection - a guide to diagnosis].

45. Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524.

46. Calicivirus Infection in Cats.

47. Vaccination of Immunocompromised Cats.

48. Role of Feline Coronavirus as Contributor to Diarrhea in Cats from Breeding Catteries.

49. First molecular evidence of Mycoplasma haemocanis and 'Candidatus Mycoplasma haematoparvum' infections and its association with epidemiological factors in dogs from Cuba.

50. A Pre- and Within-Pandemic Survey of SARS-CoV-2 RNA in Saliva Swabs from Stray Cats in Switzerland.